Author:
Mohan Ajitha,Banerjee Suparna,Sekar Kanagaraj
Reference36 articles.
1. Anderson, A. C. (2003). The process of structure-based drug design. Chemistry and Biology, 10(9), 787–797.
2. Antel, J. (1999). Integration of combinatorial chemistry and structure-based drug design. Current Opinion in Drug Discovery and Development, 2(3), 224–233.
3. Brenke, R., Kozakov, D., Chuang, G. Y., Beglov, D., Hall, D., Landon, M. R., et al. (2009). Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques. Bioinformatics, 25(5), 621–627.
4. Edla, D. R., Jana, P. K., & Member, I. S. (2012) A prototype-based modified DBSCAN for gene clustering. Procedia Technology. 6(1), 485–492. https://doi.org/10.1016/j.protcy.2012.10.058
5. Feinstein, W., & Brylinski, M. (2016). Structure-based drug discovery accelerated by many-core devices. Current Drug Targets, 17(14), 1595–1609.